In‐Vitro Activity of Miltefosine and Voriconazole on Clinical Isolates of Free‐Living Amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri
- 2 February 2006
- journal article
- Published by Wiley in The Journal of Eukaryotic Microbiology
- Vol. 53 (2), 121-126
- https://doi.org/10.1111/j.1550-7408.2005.00082.x
Abstract
The anticancer agent miltefosine and the antifungal drug voriconazole were tested in vitro against Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. All three amebas are etiologic agents of chronic (Balamuthia, Acanthamoeba) or fulminant (Naegleria) encephalitides in humans and animals and, in the case of Acanthamoeba, amebic keratitis. Balamuthia exposed to or=40 microM were generally amebacidal, with variation in sensitivity between strains. At amebastatic drug concentrations, recovery from drug effects could take as long as 2 weeks. Acanthamoeba spp. recovered from exposure to 40 microM, but not 80 microM miltefosin. Attempts to define more narrowly the minimal inhibitory (MIC) and minimal amebacidal concentrations (MAC) for Balamuthia and Acanthamoeba were difficult due to persistence of non-proliferating trophic amebas in the medium. For N. fowleri, 40 and 55 microM were the MIC and MAC, respectively, with no trophic amebas seen at the MAC. Voriconazole had little or no inhibitory effect on Balamuthia at concentrations up to 40 microg/ml, but had a strong inhibitory effect upon Acanthamoeba spp. and N. fowleri at all drug concentrations through 40 microg/ml. Following transfer to drug-free medium, Acanthamoeba polyphaga recovered within a period of 2 weeks; N. fowleri amebas recovered from exposure to 1 microg/ml, but not from higher concentrations. All testing was done on trophic amebas; drug sensitivities of cysts were not examined. Miltefosine and voriconazole are potentially useful drugs for treatment of free-living amebic infections, though sensitivities differ between genera, species, and strains.Keywords
This publication has 28 references indexed in Scilit:
- Inability To Make a Premortem Diagnosis of Acanthamoeba Species Infection in a Patient with Fatal Granulomatous Amebic EncephalitisJournal of Clinical Microbiology, 2005
- Identification and Distribution of Acanthamoeba Species Genotypes Associated with Nonkeratitis InfectionsJournal of Clinical Microbiology, 2005
- Development of Colorimetric Microtiter Plate Assay for Assessment of Antimicrobials against AcanthamoebaJournal of Clinical Microbiology, 2005
- Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovaniAntimicrobial Agents and Chemotherapy, 2004
- Cytotoxic Activities of Alkylphosphocholines against Clinical Isolates of Acanthamoeba sppAntimicrobial Agents and Chemotherapy, 2002
- Effects of Miltefosine and Other Alkylphosphocholines on Human Intestinal Parasite Entamoeba histolyticaAntimicrobial Agents and Chemotherapy, 2001
- The Evolutionary History of the Genus Acanthamoeba and the Identification of Eight New 18S rRNA Gene Sequence TypesThe Journal of Eukaryotic Microbiology, 1998
- Comparative Effects of Selected Azole Compounds on Trophic and Cystic Stages of Acanthamoeba polyphagaThe Journal of Eukaryotic Microbiology, 1993
- Sterols of Acanthamoeba culbertsoni strain A-1Steroids, 1988
- Successful Treatment of Primary Amebic MeningoencephalitisNew England Journal of Medicine, 1982